감시 림프절 생검 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)
Sentinel Node Biopsy Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드 : 1818216
리서치사 : Lucintel
발행일 : 2025년 09월
페이지 정보 : 영문 150 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,850 ₩ 5,596,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,650 ₩ 6,759,000
PDF (2 Users License) help
PDF 보고서를 동일 사업장에서 2명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,350 ₩ 7,777,000
PDF (5 Users License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,050 ₩ 10,248,000
PDF (Corporate License) help
PDF 보고서를 기업 내 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 감시 림프절 생검 시장의 미래는 병원·진료소와 진단 센터 시장에서의 기회로 유망시되고 있습니다. 세계의 감시 림프절 생검 시장은 2025-2031년에 CAGR 7.1%로 성장할 전망입니다. 이 시장의 주요 촉진요인은 최소침습적 치료에 대한 선호도 증가와 개인별 맞춤 치료 계획에 대한 수요 증가입니다.

센티넬 림프절 생검 시장의 새로운 동향

센티넬 림프절 생검 시장은 성장과 개발에 영향을 미치는 몇 가지 신흥 동향에 의해 형성되고 있습니다. 이러한 추세는 기술의 발전, 환자의 선호도 변화, 의료 시스템의 변화를 반영하고 있습니다. 정확하고 최소침습적인 암 진단에 대한 수요가 증가함에 따라 이러한 요구에 부응하기 위한 새로운 기술과 시술이 도입되고 있습니다. 센티넬 림프절 생검 시장을 변화시키는 주요 동향에는 영상 진단 기술 강화, AI 통합, 외래 환자 시술 선호도 증가 등이 있습니다. 이러한 추세는 환자의 예후를 개선할 뿐만 아니라, 세계 헬스케어 시장 수요 증가에 대응하기 위해 시장 기업에게 혁신의 기회를 제공합니다.

센티넬 림프절 생검 시장의 이러한 새로운 동향은 암 진단과 치료가 계속 발전하고 있음을 반영합니다. 향상된 영상 진단, AI 통합, 최소 침습 기술, 외래 시술, 맞춤형 의료의 조합은 센티넬 림프절 생검을 시행하고 인식하는 방식을 재구성하고 있습니다. 이러한 추세가 가속화됨에 따라 센티넬 림프절 생검 시장의 성장이 촉진될 것이며, 보다 쉽고 정확하고 효율적인 접근이 가능해질 것으로 보입니다. 이러한 변화를 수용하는 의료 시스템은 아마도 환자 예후를 개선하고, 자원 활용도를 향상시키며, 현대 암 치료에서 감시 림프절 생검의 역할을 더욱 확고히 할 수 있을 것입니다.

센티넬 림프절 생검 시장의 최근 동향

최근 센티넬 림프절 생검 시장에서 몇 가지 주요 발전이 있었습니다. 이러한 발전은 센티넬 림프절 생검의 정확성, 효율성, 접근성을 향상시키는 데 기여하고 있습니다. 첨단 영상 진단 시스템, 로봇 수술과 같은 기술 혁신은 프로세스를 간소화하고 환자 결과를 개선하고 있습니다. 또한 주요 시장의 규제 당국은 암 조기 발견의 중요성을 인식하고, 보다 진보된 센티넬 림프절 생검 기기를 승인하고 있습니다. 센티넬 림프절 생검 시장이 발전함에 따라 이러한 발전은 전 세계에서 성장하고 암 치료를 개선할 수 있는 기회를 창출하고 있습니다.

센티넬 림프절 생검 시장의 최근 동향은 영상 기술의 발전, 규제 당국의 승인, 최소침습적 시술에 대한 관심 증가 등으로 인해 이 분야의 판도를 바꾸고 있습니다. 더 많은 장비가 승인되고 기술이 향상됨에 따라 시술은 더 안전하고, 더 정확하고, 더 최소 침습적으로 변하고 있습니다. 또한 암 발병률 증가와 조기 발견에 대한 노력이 시장 수요를 견인하고 있습니다. 헬스케어 인프라가 구축되고 있는 신흥 시장도 시장 성장에 기여하고 있습니다. 이러한 발전으로 센티넬 림프절 생검 시장은 지속적으로 성장하고 있으며, 현대의 암 진단 및 치료에 필수적인 요소로 자리매김하고 있습니다.

목차

제1장 개요

제2장 시장 개요

제3장 시장 동향과 예측 분석

제4장 유형별 감시 림프절 생검 시장

제5장 용도별 감시 림프절 생검 시장

제6장 지역 분석

제7장 북미의 감시 림프절 생검 시장

제8장 유럽의 감시 림프절 생검 시장

제9장 아시아태평양의 감시 림프절 생검 시장

제10장 기타 지역의 감시 림프절 생검 시장

제11장 경쟁 분석

제12장 기회와 전략 분석

제13장 밸류체인 전체에 걸친 주요 기업의 기업 개요

제14장 부록

KSA
영문 목차

영문목차

The future of the global sentinel node biopsy market looks promising with opportunities in the hospitals & clinics and diagnostic centers markets. The global sentinel node biopsy market is expected to grow with a CAGR of 7.1% from 2025 to 2031. The major drivers for this market are the increasing preference for minimally invasive procedures and the rising demand for personalized treatment plans.

Emerging Trends in the Sentinel Node Biopsy Market

The sentinel node biopsy market is shaped by several emerging trends that influence its growth and development. These trends reflect technological advancements, evolving patient preferences, and healthcare system changes. As demand for accurate and minimally invasive cancer diagnostics increases, new technologies and procedures are being introduced to meet these needs. The key trends transforming the SNB market include enhanced imaging techniques, AI integration, and the increasing preference for outpatient procedures. These trends not only improve patient outcomes but also create opportunities for market players to innovate and meet the growing demand in global healthcare markets.

These emerging trends in the sentinel node biopsy market reflect the ongoing evolution of cancer diagnostics and treatment. The combination of enhanced imaging, AI integration, minimally invasive techniques, outpatient procedures, and personalized medicine is reshaping how sentinel node biopsies are performed and perceived. As these trends continue to gain momentum, they will drive the growth of the SNB market, making it more accessible, accurate, and efficient. Healthcare systems that embrace these changes will likely see improved patient outcomes and better resource utilization, further solidifying the role of SNB in modern cancer care.

Recent Developments in the Sentinel Node Biopsy Market

In recent years, several key developments have emerged in the sentinel node biopsy market. These advancements are helping to improve the accuracy, efficiency, and accessibility of SNB procedures. Technological innovations, such as advanced imaging systems and robotic surgery, are streamlining the process and improving patient outcomes. Additionally, regulatory bodies in key markets are approving more advanced SNB devices, and there is growing recognition of the importance of early cancer detection. As the SNB market evolves, these developments are creating opportunities for growth and improved cancer care worldwide.

The recent developments in the sentinel node biopsy market, including advancements in imaging technology, regulatory approvals, and the increased emphasis on minimally invasive techniques, are reshaping the field. As more devices are approved and technologies improve, the procedures are becoming safer, more accurate, and less invasive. Additionally, the rise in cancer incidence and efforts for early detection are driving market demand. Emerging markets with improving healthcare infrastructure are also contributing to market growth. These developments are positioning the SNB market for sustained growth, making it a crucial component of modern cancer diagnosis and treatment.

Strategic Growth Opportunities in the Sentinel Node Biopsy Market

The sentinel node biopsy market is poised for significant growth, with various strategic opportunities across key applications. These growth opportunities are being driven by technological advancements, increasing demand for cancer diagnostics, and the push toward personalized medicine. As cancer detection and staging technologies evolve, the SNB market is expected to benefit from new product innovations, improved procedures, and the expansion of healthcare access globally. Identifying and capitalizing on growth opportunities within key applications will allow stakeholders to strengthen their market position and contribute to improved patient outcomes in cancer care.

The sentinel node biopsy market is experiencing strategic growth across multiple applications, driven by technological advancements and increasing cancer prevalence. Key growth opportunities lie in breast cancer diagnosis, melanoma detection, prostate cancer staging, ovarian cancer diagnosis, and the adoption of robotic-assisted procedures. These trends are transforming the SNB market by improving diagnostic accuracy, patient outcomes, and the overall efficiency of cancer care. As stakeholders continue to innovate and capitalize on these opportunities, the SNB market is expected to expand significantly, further cementing its importance in modern oncology.

Sentinel Node Biopsy Market Driver and Challenges

The sentinel node biopsy market is influenced by a variety of drivers and challenges stemming from technological, economic, and regulatory factors. On the one hand, advancements in imaging technologies and growing demand for early cancer detection are propelling market growth. On the other hand, challenges such as regulatory hurdles, cost pressures, and issues surrounding the availability of trained professionals continue to impact the market. Understanding these drivers and challenges is essential for stakeholders to navigate the evolving landscape of the SNB market and capitalize on opportunities while addressing potential obstacles.

The factors responsible for driving the sentinel node biopsy market include:

1. Technological Advancements: Technological advancements, especially in imaging techniques like near-infrared fluorescence imaging, have significantly enhanced the accuracy of sentinel node biopsy procedures. These innovations have led to better patient outcomes by ensuring precise identification of sentinel lymph nodes. As technology continues to evolve, SNB procedures will become even more effective and less invasive, driving demand for these procedures globally. The incorporation of AI in imaging and analysis further accelerates the market growth by reducing human error and improving diagnostic precision.

2. Increasing Cancer Incidence: The rising global incidence of cancer is one of the primary drivers behind the growth of the SNB market. As cancer cases continue to rise, especially in regions with aging populations, the demand for early detection methods such as SNB increases. Early detection plays a key role in determining treatment plans and improving patient survival rates. The global focus on improving cancer care and outcomes will continue to drive the demand for SNB procedures as a critical tool in cancer staging and management.

3. Minimally Invasive Surgery Demand: The growing preference for minimally invasive surgery is another major driver of the SNB market. Patients and healthcare providers alike are prioritizing techniques that result in less trauma, faster recovery, and reduced risk of complications. Sentinel node biopsy, which is less invasive than traditional methods, aligns well with these demands. The shift toward minimally invasive procedures, particularly in cancer diagnostics, is expected to continue fueling the growth of the SNB market.

4. Increased Government and Private Sector Investments: Government and private sector investments in healthcare infrastructure and cancer research are helping to expand the use of advanced diagnostic techniques like sentinel node biopsy. With greater funding for cancer research, especially in emerging markets, SNB procedures are becoming more accessible, leading to market growth. Additionally, investments in healthcare infrastructure are improving access to quality cancer diagnostics in underserved regions, creating new opportunities for SNB adoption.

5. Patient-Centric Healthcare Focus: There is a growing focus on patient-centric care, with an emphasis on improving patient outcomes and reducing treatment-related discomfort. As a result, patients increasingly prefer minimally invasive procedures like sentinel node biopsy, which offer shorter recovery times, less pain, and better overall experiences. This shift towards more patient-friendly treatments is driving the demand for SNB procedures and influencing healthcare providers to adopt the latest technologies to meet these preferences.

Challenges in the sentinel node biopsy market are:

1. Regulatory and Reimbursement Issues: Regulatory challenges can slow the adoption of new technologies and procedures in the SNB market. Different regions have varying regulatory standards for medical devices, which can lead to delays in product approval. Additionally, reimbursement policies can impact the accessibility of SNB procedures, particularly in regions where insurance coverage for advanced diagnostic tools is limited. These regulatory and reimbursement issues may hinder the market's expansion in certain regions.

2. High Costs and Financial Constraints: The cost of advanced sentinel node biopsy devices, along with the expenses related to surgical procedures and imaging technologies, can be a significant barrier to market growth. In many regions, the high cost of these procedures may limit access to SNB, particularly in low-income populations or emerging markets. Financial constraints, both at the institutional and patient levels, could slow the widespread adoption of SNB procedures.

3. Lack of Skilled Professionals: Performing a sentinel node biopsy requires specialized training and expertise. In many regions, a shortage of skilled professionals can limit the availability and effectiveness of SNB procedures. This shortage can also lead to longer wait times for procedures, reduced patient access to high-quality care, and ultimately hinder the market's growth. Efforts to address this challenge include increasing training programs and improving the use of AI and robotics to assist in the procedure.

The sentinel node biopsy market is driven by technological advancements, increasing cancer incidence, the growing demand for minimally invasive surgery, and investments in healthcare infrastructure. However, challenges such as regulatory hurdles, high costs, and the shortage of skilled professionals are hindering market growth. Addressing these challenges through improved regulations, cost reduction efforts, and expanding professional training will be crucial for the market's continued success. Overall, as the drivers outweigh the challenges, the SNB market is expected to expand, offering improved diagnostic tools and treatment options for cancer patients worldwide.

List of Sentinel Node Biopsy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies sentinel node biopsy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the sentinel node biopsy companies profiled in this report include-

Sentinel Node Biopsy Market by Segment

The study includes a forecast for the global sentinel node biopsy market by type, application, and region.

Sentinel Node Biopsy Market by Type [Value from 2019 to 2031]:

Sentinel Node Biopsy Market by Application [Value from 2019 to 2031]:

Sentinel Node Biopsy Market by Region [Value from 2019 to 2031]:

Country Wise Outlook for the Sentinel Node Biopsy Market

The sentinel node biopsy market has witnessed significant growth due to its critical role in cancer staging and treatment planning. This procedure allows for the detection of early metastases by analyzing the sentinel lymph node, which is the first site to receive cancerous cells from a tumor. The demand for SNB procedures is expected to rise in countries such as the United States, China, Germany, India, and Japan. In these regions, technological advancements, increasing cancer prevalence, and better healthcare infrastructure are major contributors to the growing SNB market.

Features of the Global Sentinel Node Biopsy Market

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Market Overview

3. Market Trends & Forecast Analysis

4. Global Sentinel Node Biopsy Market by Type

5. Global Sentinel Node Biopsy Market by Application

6. Regional Analysis

7. North American Sentinel Node Biopsy Market

8. European Sentinel Node Biopsy Market

9. APAC Sentinel Node Biopsy Market

10. ROW Sentinel Node Biopsy Market

11. Competitor Analysis

12. Opportunities & Strategic Analysis

13. Company Profiles of the Leading Players Across the Value Chain

14. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기